KAILIAN VAUGHN M

CIK 000118042914 companiesBOSTON, MA

SEC Profile

Transactions

Companies

Filings

CIK

0001180429

Recent Transactions

50 trades

Other
Radius Health, Inc.
Common Stock
2016-09-27−713,849→ 1,427,698 total
Conversion
Syndax Pharmaceuticals Inc$SNDX
Common Stock
2016-03-08+1,138,210→ 1,138,210 total
Conversion
Syndax Pharmaceuticals Inc$SNDX
Series A-1 Preferred Stock
2016-03-08−1,138,210→ 0 total
Conversion
Syndax Pharmaceuticals Inc$SNDX
Common Stock
2016-03-08+718,396→ 1,856,606 total
Conversion
Syndax Pharmaceuticals Inc$SNDX
Series C-1 Preferred Stock
2016-03-08−312,085→ 0 total
Conversion
Syndax Pharmaceuticals Inc$SNDX
Series B-1 Preferred Stock
2016-03-08−718,396→ 0 total
Conversion
Syndax Pharmaceuticals Inc$SNDX
Common Stock
2016-03-08+312,085→ 2,168,691 total
Conversion
Avalo Therapeutics, Inc.$AVTX
Common Stock
2015-10-20+595,436→ 595,436 total
Conversion
Avalo Therapeutics, Inc.$AVTX
Series B Convertible Preferred Stock
2015-10-20−16,672,224→ 0 total
Conversion
CHIASMA, INC
Common Stock
2015-07-21+2,488,171→ 2,498,597 total
Conversion
CHIASMA, INC
Series B-1' Preferred Stock
2015-07-21−95,225→ 0 total
Conversion
CHIASMA, INC
Series C' Preferred Stock
2015-07-21−22,721,988→ 0 total
Conversion
CHIASMA, INC
Series E Preferred Stock
2015-07-21−13,000,000→ 0 total
Conversion
CHIASMA, INC
Common Stock
2015-07-21+1,759,381→ 4,257,978 total
Conversion
CHIASMA, INC
Common Stock
2015-07-21+1,423,566→ 5,681,544 total
Conversion
CHIASMA, INC
Series D' Preferred Stock
2015-07-21−16,066,669→ 0 total
Conversion
CHIASMA, INC
Common Stock
2015-07-21+10,426→ 10,426 total
Sale
ARATANA THERAPEUTICS, INC.
Common Stock
2014-03-10$20.02/sh−600,000→ 2,751,048 total
Other
ARATANA THERAPEUTICS, INC.
Common Stock
2014-03-03−1,000,000→ 3,351,048 total
Other
ARATANA THERAPEUTICS, INC.
Common Stock
2014-03-03+20,876→ 38,386 total
Other
ARATANA THERAPEUTICS, INC.
Common Stock
2014-03-03+12,247→ 12,393 total
Other
ARATANA THERAPEUTICS, INC.
Common Stock
2014-03-03+37,117→ 37,117 total
Other
ARATANA THERAPEUTICS, INC.
Common Stock
2014-03-03+20,876→ 26,713 total
Other
ARATANA THERAPEUTICS, INC.
Common Stock
2014-03-03+15,310→ 17,937 total
Other
ARATANA THERAPEUTICS, INC.
Common Stock
2014-03-03+20,876→ 22,767 total
Sale
Epizyme, Inc.
Common Stock
2014-02-10$29.25/sh−466,666→ 2,413,819 total
Other
Histogen Inc.
Common Stock
2013-07-30$11.00/sh+16,716→ 1,026,815 total
Purchase
Histogen Inc.
Common Stock
2013-07-30$11.00/sh+165,265→ 1,192,080 total
Conversion
Histogen Inc.
Common Stock
2013-07-30+1,010,099→ 1,010,099 total
Conversion
Histogen Inc.
Series B Convertible Preferred Stock
2013-07-30−8,333,334→ 0 total
Conversion
Histogen Inc.
Warrant to Purchase Common Stock (Right to Buy)
2013-07-30+32,220→ 32,220 total
Conversion
Histogen Inc.
Warrant to Purchase Series B Preferred Stock (Right to Buy)
2013-07-30−265,837→ 0 total
Conversion
ARATANA THERAPEUTICS, INC.
Series A Preferred Stock
2013-07-02−4,000,000→ 0 total
Conversion
ARATANA THERAPEUTICS, INC.
Common Stock
2013-07-02+225,631→ 3,851,050 total
Conversion
ARATANA THERAPEUTICS, INC.
Common Stock
2013-07-02+2,406,739→ 2,823,173 total
Conversion
ARATANA THERAPEUTICS, INC.
Series B Preferred Stock
2013-07-02−1,333,333→ 0 total
Conversion
ARATANA THERAPEUTICS, INC.
Common Stock
2013-07-02+802,246→ 3,625,419 total
Purchase
ARATANA THERAPEUTICS, INC.
Common Stock
2013-07-02$6.00/sh+500,000→ 4,351,050 total
Conversion
ARATANA THERAPEUTICS, INC.
Series C Preferred Stock
2013-07-02−375,000→ 0 total
Conversion
Epizyme, Inc.
Common Stock
2013-06-05+2,309,998→ 2,488,329 total
Conversion
Epizyme, Inc.
Common Stock
2013-06-05+392,156→ 2,880,485 total
Conversion
Epizyme, Inc.
Series A Preferred Stock
2013-06-05−6,930,000→ 0 total
Conversion
Epizyme, Inc.
Series B Preferred Stock
2013-06-05−1,176,472→ 0 total
Purchase
Radius Health, Inc.
Common Stock Warrant
2013-04-23$6.14/sh+179,095→ 179,095 total
Purchase
Radius Health, Inc.
Series B Convertible Preferred Stock
2013-04-23$61.42/sh+71,638→ 71,638 total
Sale
Pacira BioSciences, Inc.$PCRX
Common Stock
2013-03-11$27.86/sh−500,000→ 2,790,479 total
Conversion
Pacira BioSciences, Inc.$PCRX
Convertible Promissory Note
2012-02-08−712,567→ 0 total
Purchase
Pacira BioSciences, Inc.$PCRX
Common Stock
2012-02-08$7.00/sh+267,857→ 2,561,084 total
Purchase
Pacira BioSciences, Inc.$PCRX
Common Stock
2012-02-08$7.00/sh+267,857→ 2,828,941 total
Conversion
Pacira BioSciences, Inc.$PCRX
Common Stock
2012-02-08+712,567→ 2,293,227 total

KAILIAN VAUGHN M

Recent Transactions

Companies

Recent Filings

Address